Value-Based Palliative Care Moving Toward At-Risk Models

Risk-based contracts may be the future of palliative care reimbursement as Medicare Advantage continues to ascend. The simple term “value-based care” belies its complexity. The term can refer to any number of payment models that are designed to reduce total cost of care and improve outcomes. While most palliative care remains locked in the fee-for-service […]

UnitedHealth Group Withdraws Motion To Dismiss DOJ’s Amedisys Lawsuit

UnitedHealth Group Inc. (NYSE: UNH) is withdrawing its motion to dismiss the U.S. Department of Justice’s (DOJ) antitrust lawsuit regarding the company’s plans to acquire Amedisys in a $3.3 billion deal. UnitedHealth Group is one of the largest companies in the country and has an array of associated business lines. Should the deal go through, […]

Inside Palliative Care at Contessa’s Health System Joint Ventures

Contessa, the innovation and high-acuity arm of Amedisys Inc. (NASDAQ: AMED) has made large investments in expanding access to palliative care, particularly through joint ventures with health systems. Amedisys acquired Contessa in 2021 for $250 million. The subsidiary’s specialty is high-acuity care in the home, including hospital-at-home and skilled nursing facility-at-home programs, but in recent […]

The Current State of Community-Based Palliative Care

Want to read more palliative care-focused content like this? Subscribe to Palliative Care News today! With the palliative care space in a state of flux, some experts in the field see cause for optimism as well as real questions about what these services will look like, as well as the structures that support them. “Palliative care” […]

Growing Palliative Care a Key Priority for Amedisys in 2024

Want to read more palliative care-focused content like this? Subscribe to Palliative Care News today! Amedisys (NASDAQ: AMED) is pushing forward on palliative care growth in 2024 through its innovation arm, Contessa. The company acquired Contessa in 2021 for $250 million. Contessa’s specialties are high-acuity care in the home, including hospital-at-home and skilled nursing facility-at-home programs. […]

Provider Partnerships Driving Palliative Care Growth

An increasingly diverse base of health care providers have taken an interest in the palliative care space, a trend that could be indicative of how strategic growth is taking shape in the field. As they build out their palliative care programs, many of these organizations are pursuing partnerships to foster coordination and growth. A range […]

Contessa’s Lessons Learned on Risk-Based Palliative Care

As Contessa Health pioneers a growing value-based palliative care-at-home program, they’ve encountered some learning curves when it comes to operating within a new payment system. Contessa is a subsidiary of Amedisys (NASDAQ: AMED), which the home health and hospice provider acquired in 2021 for $250 million. Contessa’s specialty is high-acuity care in the home, including […]

[UPDATED] Palliative Care Leaders Expect Continued Growth, Labor and Reimbursement Headwinds in 2024

The palliative care space is at an inflection point at which unprecedented awareness and demand are fueling growth that could be hampered by limited reimbursement and staffing shortages. Palliative Care News spoke with a group of industry leaders about the most impactful forces that will shape the space in the coming year. Some of the […]

How to ‘Sell’ Palliative Care to Health System Partners

Establishing consistent relationships with referral sources will not only fill palliative care programs’ business pipelines, but it will also allow providers to develop better delivery models to meet the needs of their partners and patients. As value-based models expand and hold health systems accountable for the entire care continuum, palliative care partnerships and joint ventures […]

How Contessa’s Palliative Care Business Factored Into the Amedisys-Optum Transaction

Negotiations around Amedisys Inc.’s (NASDAQ: AMED) Contessa subsidiary were a significant contributor to the pendulum swing that led to the company’s acquisition by UnitedHealth Group’s (NYSE: UNH) Optum rather than Option Care Health (NASDAQ: OPCH). Optum in June penned its agreement to acquire Amedisys in an all-cash transaction of $101 per share, or about $3.3 […]